Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: The Italian Sarcoma Group Experience (1983-2006)

Cancer

Volumn 118, Issue 20, 2012, Pages 5050-5059

  Longhi, Alessandra ^a   Ferrari, Stefano ^a   Tamburini, Angela ^b   Luksch, Roberto ^c   Fagioli, Franca ^d   Bacci, Gaetano ^a   Ferrari, Cristina ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

bone sarcoma; cardiotoxicity; childhood cancer survivors; infertility; second malignant neoplasm

Indexed keywords

DOXORUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANGIOSARCOMA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CHILD; COLON CANCER; CONTROLLED STUDY; DRUG SAFETY; EWING SARCOMA; FEMALE; FEMALE INFERTILITY; GLIOBLASTOMA; HEART DISEASE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MALE STERILITY; MELANOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; OVARY CANCER; PAROTID GLAND CANCER; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SECOND CANCER; SKIN CARCINOMA; SOFT TISSUE SARCOMA; THERAPY EFFECT; THYROID CANCER; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; INFANT; INFERTILITY; MALE; NEOPLASMS, SECOND PRIMARY; OSTEOSARCOMA; SARCOMA, EWING; SURVIVORS; YOUNG ADULT;

EID: 84867335639     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27493     Document Type: Article

References (31)

1. Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P,. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer. 2005; 41: 2836-2845.
2. Yeh JM, Nekhlyudov L, Goldie SJ, Mertens AC, Diller L,. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med. 2010; 152: 409-417, W131-W138.
3. Bacci G, Longhi A, Barbieri E, et al. Second malignancy in 597 patients with Ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999. J Pediatr Hematol Oncol. 2005; 27: 517-520.
4. Bacci G, Picci P, Ruggieri P, et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intra-arterial cisplatin. Cancer. 1990; 65: 2539-2553.
5. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000; 18: 4016-4027.
6. Ferrari S, Mercuri M, Picci P, et al. Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intra-arterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response. Tumouri. 1999; 85: 458-464.
7. Bacci G, Briccoli A, Ferrari S, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Eur J Cancer. 2001; 37: 2030-2039.
8. Bacci G, Ferrari S, Longhi A, et al. High dose ifosfamide in combination with high dose methotrexate, Adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother. 2002; 14: 198-206.
9. Ferrari S, Smeland S, Mercuri M, et al. Italian and Scandinavian Sarcoma Groups. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol. 2005; 23: 8845-8852.
10. Ferrari S, Cefalo G, Tamburini A, et al. Nonmetastatic osteosarcoma of the extremity: neoadjuvant chemotherapy with methotrexate (MTX), cisplatin (CDP), doxorubicin (ADM) with or without ifosfamide (IFO) - A randomized trial of the Italian Sarcoma Group (ISG/OS-1). Paper presented at: Annual Meeting of the American Society of Clinical Oncology; June 4-8, 2010; Chicago IL.
11. Bacci G, Ferrari S, Avella M, et al. Nonmetastatic Ewing's sarcoma: results in 98 patients treated with neoadjuvant chemotherapy. Ital J Orthop Traumatol. 1991; 17: 449-465.
12. Bacci G, Ferrari S, Rosito P, et al. Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, Adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide) [article in Italian]. Minerva Pediatr. 1995; 47: 457-469.
13. Bacci G, Mercuri M, Longhi A, et al. Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute. Eur J Cancer. 2002; 38: 2243-2251.
14. Ferrari S, Sundby Hall K, Luksch R, et al. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. Ann Oncol. 2011; 22: 1221-1227.
15. Kalbfleisch JD, Prentice RL,. The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons, Inc.; 1980.
16. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006; 355: 1572-1582.
17. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in 5-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst. 2001; 93: 618-629.
18. Robison LL, Green DM, Hudson M, et al. Long-term outcomes of adult survivors of childhood cancer. Cancer. 2005; 104 (11 suppl): 2557-2564.
19. Nagarajan R, Kamruzzaman A, Ness KK, et al. Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Childhood Cancer Survivor Study. Cancer. 2011; 117: 625-634.
20. Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004; 141: 590-597.
21. Baussano I, Maule MM, Dama E, et al. Expected number of childhood cancers in Italy from 2001 to 2015. Haematologica. 2007; 92: 1258-1261.
22. Oeffinger KC, Bhatia S,. Second primary cancers in survivors of childhood cancer. Lancet. 2009; 374: 1484-1485.
23. Ginsberg JP, Goodman P, Leisenring W, et al. Long-term survivors of childhood Ewing sarcoma: report from the Childhood Cancer Survivor Study. J Nat Cancer Inst. 2010; 102: 1272-1283.
24. Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 1995; 332: 1738-1743.
25. Longhi A, Macchiagodena M, Vitali G, Bacci G,. Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol. 2003; 25: 292-296.
26. Longhi A, Porcu E, Petracchi S, Versari M, Conticini L, Bacci G,. Reproductive functions in female patients treated with adjuvant and neoadjuvant chemotherapy for localized osteosarcoma of the extremity. Cancer. 2000; 89: 1961-1965.
27. Hsiao W, Stahl PJ, Osterberg EC, et al. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. J Clin Oncol. 2011; 29: 1607-1611.
28. Grzegorczyk V, Perdrix A, Clavier B, Mousset-Simeon N, Rives N, Marpeau L,. Conventional in vitro fertilization and intracytoplasmic sperm injection in sibling oocytes following intrauterine inseminations failure [article in French]. Gynecol Obstet Fertil. 2011; 39: 211-215.
29. Casper ES, Gaynor JJ, Hajdu SI, et al. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors. Cancer. 1991; 68: 1221-1229.
30. Pratt CB, Ransom J, Evans WE,. Age-related Adriamycin cardiotoxicity in children. Cancer Treat Rep. 1978; 62: 1381-1385.
31. Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE,. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol. 1997; 15: 1544-1552.